Pooling in directed-evolution experiments will greatly increase the throughput of screening systems, but important parameters such as the number of good mutants created and the activity level increase of the good mutants will depend highly on the protein being engineered. The authors developed and validated a Monte Carlo simulation model of pooling that allows the testing of various scenarios in silico before starting experimentation. Using a simplified test system of 2 enzymes, βgalactosidase (supermutant, or greatly improved enzyme) and β-glucuronidase (dud, or enzyme with ancestral level of activity), the model accurately predicted the number of supermutants detected in experiments within a factor of 2. Additional simulations using more complex activity distributions show the versatility of the model. Pooling is most suited to cases such as the directed evolution of new function in a protein, where the background level of activity is minimized, making it easier to detect small increases in activity level. Pooling is most successful when a sensitive assay is employed. Using the model will increase the throughput of screening procedures for directed-evolution experiments and thus lead to speedier engineering of proteins. (Journal of Biomolecular Screening 2005:856-864) 
INTRODUCTION
P OOLING IS THE SIMULTANEOUS ANALYSIS of multiple samples followed by the deconvolution of pools that show promising results. Similar techniques have been used to increase throughput in combinatorial chemistry for drug discovery, 1,2 genome sequencing and chromosome mapping, [3] [4] [5] [6] oligonucleotide microarrays, 7, 8 and testing of biological samples such as blood for the presence of organisms, contaminants, or characteristics of interest. [9] [10] [11] [12] As noted by Bruno et al, 5 "Whenever the objective is to find 'needles in a haystack' a reliable test indicating whether at least one needle occurs in a specific part of the haystack can greatly facilitate the isolation of the needles." In each case, the object is to balance the increase in sample size obtained by pooling with the decrease in ability to detect the analyte of interest. If pools become too large, the signal from the organism in question will be lost in the background of the assay.
Directed evolution is an iterative method of protein engineering in which 1 or more genes that code for the protein of interest are subjected to random mutagenesis or recombination. 13, 14 The resulting variants, or mutant proteins, must then be sorted into good and bad performers. If the activity of interest cannot be tied to host survival (selection), then each mutant must be assayed individually, a process called screening. Because of the time-and resourceintensive nature of screening, laboratories are typically limited to screening 10 5 to 10 7 mutants per round of directed evolution. 15 The capacity limit affects the way error-prone PCR experiments are conducted: because the higher the mutation frequency, the larger the number of inactive mutants, experimenters typically do not make more than 1 to 2 mutations per gene to ensure that the majority of mutants screened have at least some activity. 16 Although this policy means that most of the library screened will be active, it decreases the amount of sequence space that can be accessed. Therefore, if great improvement in the protein of interest requires many mutations, the probability that this solution will be tested is very low. In addition, when recombination methods are used to generate diversity, the proteins that are actually assayed represent a very small portion of the ones that are produced. Therefore, it is likely that many improved proteins are missed because of the limitations of assay throughput.
We propose to extend the concept of pooling to the directed evolution of proteins. However, the level of pooling that can be tolerated in any system will depend on several factors such as the background level of activity that the parental strain possesses, the accuracy level of the assay in question, how frequently improved mutants are produced, and what level of improvement is achieved by these mutants. The optimal level of pooling will vary with the particular situation at hand; therefore, it would be useful to have a simulation model to test different conditions in silico before planning experiments.
To validate the proposed model, a highly controlled experimental system with a colorimetric reporter assay was used. A 1st-level test system was composed of 2 enzymes, β-galactosidase (LacZ) and β-glucuronidase (Gus), which are thought to be evolutionarily related, and both catalyze hydrolytic reactions involving carbohydrates. 17, 18 β-Glucuronidase does catalyze the hydrolysis of the substrate of β-galactosidase but at an approximately 10 6 -fold lower level. A mixture of LacZ and Gus thus comprises a binary system for which direct calculations of the probability of finding an improved enzyme can be made, providing further corroboration of the accuracy of the model. In addition, directed-evolution experiments to increase this activity have been conducted, [19] [20] [21] yielding mutants of various levels of galactosidase activity with which we could test more complex activity distributions. Finally, several reporter compounds are available to detect galactosidase activity; most of these allow for visual detection of the presence of a supermutant. Thus, these enzymes and their mutants comprise a system that can be used to validate the model in a controlled manner.
MATERIALS AND METHODS

Computer simulations
The pooling experiments are complex enough that an analytical probability model of the system is unlikely to yield tractable closed-form results when considering complex assay accuracies or distributions of underlying population activity. This led to the development of a stochastic simulation model using Monte Carlo methods. 22, 23 The simulation essentially maps an idealized experimental procedure into an executable algorithm (see Fig. 1 ). Monte Carlo sampling is required whenever there is an underlying nondeterministic choice to be made. The Jet Random Number Generator from the European Center for Nuclear Research (CERN 24 ) was used to create random numbers from different probability distributions. Sampling is required during the following points in the simulation:
1. The pipetting of cells is assumed to draw a certain quantity of liquid whose volume is significantly greater than the volume of the cells that is expected to be within it. Thus, the probability that any subvolume contains a cell is thus very small, a rare event, and the number of subvolumes very large. This enables the use of the Poisson distribution to represent a single pipette action. The mean of the Poisson distribution is taken to be the intended target number of cells per well. The concentration of the cells and the quantity of the original mixture are considered to be uniform and significantly greater than the amount that is being pipetted, so the overall pro-cess is represented by a series of identical, independently distributed trials. For example, if 1 cell per well is the target, then the probability of a given cell being empty is equal to 1/e, or 0.368. 2. The activity curve for a population of cells is obtained by plotting the catalytic activity against the corresponding number of cells. A directed-evolution experiment would sample for this activity curve by creating variants. The probability of a cell having an activity within a given range is dependent on the underlying population and processes that have been used to select it. For the purposes of early model validation, cells with only 2 different levels of activity form the population. Thus, the activity curve was assumed to be a discrete probability distribution with 2 masses, the probability of a supermutant and the probability of the dud, summing to unity. Although the activities of the supermutant and dud are assumed to be fixed, it is actually an average activity of the population, and a finite spread would occur around it. However, it was unnecessary to represent this finite spread because it was assumed that it could be reflected in the assay accuracy. In later simulations, a more complex activity curve involving several mutants of varying activity levels was input. In practice, the model can handle any type of activity curve. 3. A normal distribution is used to model the assay error; however, in simulation runs involving a large activity level difference, the accuracy was sufficiently high that there was little chance that the 2 cell types could be confused because of assay error.
The simulation code was constructed to allow for tracking of the true identity of cells in each well at the end of the simulation. By examining the true identity of the cells in the wells indicated to have an improved variant, we were able to quantify the numbers of false positives.
Simulation software
The simulation code is implemented in Java for ease of use, portability, and extensibility. The object-oriented nature of Java is a perfect fit for the real-life experiments because each physical part of the process is described by a class. These classes can be individually tested and easy to replace if the model needs to be changed. Once the code is compiled, it can be used on any platform that supports a Java Virtual Machine, eliminating the need to implement different versions for different operating systems and making distribution simple.
The large scale of data being processed requires a fast computer with significant storage capability. A typical experiment has 80 well plates with 384 wells each and each well with 1 to 100 cells. Each of those 1 to 2 million cells has data that need to be stored, manipulated, and compared for each round of directed evolution. The running time for simulations on a Pentium IV 2.4-GHz processor with 512 Mb of RAM is of the order of a few minutes, depending on the number of cells per well sampled.
Verification of simulation results through the analytical probabilistic model
For the simulations involving a binary activity distribution, the modeling of the experimental results can also be approached through an analytical probabilistic model that captures the basic features of the pooling procedure. It is important to note that the assay accuracy also cannot be accounted for in the calculations, and thus this calculation could only be made for the binary system involving the wild-type LacZ versus the wild-type Gus (activity ratio [AR] = 38,000). This model was used as further corroboration of the simulation procedure.
The number of cells sampled from the initial pool is assumed to follow a Poisson distribution, for the same reason as its use in the simulation. For an average j cells/well, the probability of sampling i cells is defined as P i,j and given by
(1)
Assuming that the initial pool of cells is infinite in number and the cells taken out in samples do not affect the supermutant/dud ratio (SR), the probability of picking out i duds in a sample can be written as
where f D is the fraction of duds in the initial pool. Thus, the probability of sampling only duds or no cells when the number of cells sampled is given by a Poisson distribution with an average j is
where n is a number much larger than the average cells per well j, such that the term P i, j (f D ) i is negligible. The probability of sampling 1 or more supermutants in a well can now be written as
The probability of finding k wells with 1 or more supermutants when sampling a total of N wells with an average of j cells per well is written as
Note that the assay accuracy is assumed to be 100% in this derivation. From equation (5), the average number of supermutant cells detected for a dud ratio of f D in the pool when sampled with an average of j cells/well can be written as
Materials
Immunopure ™ o-nitrophenylgalactopyranoside was obtained from Pierce Biotechnology (Rockford, IL). All other chemicals were obtained from Sigma Aldrich (St. Louis, MO). Molecular biology reagents and LB medium were purchased through VWR International (Suwanee, GA).
Cell growth and assay conditions
Screening was conducted using cells expressing βgalactosidase as the supermutant and cells expressing βglucuronidase as the dud. Genetic constructs for each enzyme are described in detail elsewhere. 19, 25 Briefly, the gene encoding for each enzyme was cloned from Escherichia coli genomic DNA into a library of pET20b vectors in which the T7 promoter has been removed and the lac promoter randomized to produce varying levels of constitutive expression, 26 transformed into E. coli INVαF′(lacZ∆M15) cells, and selected for the optimal and most stable level of expression.
Screening assay procedures were derived from Geddie et al. 27 Initial stocks of each cell type were created by growing a single colony in Luria-Bertani (LB) medium supplemented with 100 µg/ mL of ampicillin to mid-log phase, diluting 50:50 with 33% glycerol, aliquotting into microcentrifuge tubes, and snap-freezing with liquid nitrogen. One tube of each type was then thawed and titered by serial dilution to determine the concentration prior to cell dilutions.
For each screening run, the supermutant and dud were mixed in a given ratio, the SR (1 supermutant per 10 4 , 10 5 , or 10 6 duds), and then diluted to the appropriate number of cells per 5 µL (1, 10, 40, or 100). Dilution procedures were checked using a Beckman-Coulter Multisizer 3 cell counter (Fullerton, CA). Cells were allocated to eighty 384-well plates using a Multidrop 384 (Thermo Labsystems, Waltham, MA), sealed with silicon mats (Specialty Silicon, Rochester, NY), and grown overnight at 37°C in a rotating incubator (Environmental Express, Mt. Pleasant, SC). The mats were removed, and 50 µL of substrate solution (0.5 mM ortho-nitrophenyl-galactopyranoside [oNPG] in 1× phosphatebuffered saline, pH 7.3) was added to each well. The plates were incubated at room temperature for 3 h and visually inspected for the appearance of bright yellow color, indicating the presence of the supermutant.
For tests of assay limitations and comparison of assays, forced dilutions of cells expressing the "supermutant" and the "dud" (1:10 through 1:10 5 ) as well as pure cultures of each type were grown overnight in glass culture tubes. This represents the worstcase scenario of detecting an improved mutant over the background level of activity, as the wild type has a very high level of background activity. Then, 5 µL of these cultures was dispensed into each well of a 384-well plate, 50 µL of oNPG substrate solution or 25 µL of 0.1 mM resorufin-β-D-galactopyranoside (ResGal) in 10 mM Tris-HCl (pH 7.5) was added, and plates were incubated at 30°C. After 3 h, the absorbance of the plates incubated with the oNPG substrate was read at 405 nm using a Fluorostar Galaxy (BMG Technologies, Offenburg, Germany). Plates used in the resorufin assay were incubated for 1.5 h and assayed in fluorescence mode (excitation wavelength 544 nm, emission wavelength 590 nm). Because the use of pooling in a directedevolution experiment would require a 2nd stage to isolate the true supermutants that were present in the winning well (2 sets of 80 plates would be necessary for a single set of pooled experiments), experiments of unpooled conditions were increased to a sample size of 160 plates to keep the comparison even in total effort.
Mutant with 15-fold difference in activity level
The S557P, T509A/S557P, and T509A/S557P/N566S/K568Q mutants 19, 20 were created using the QuikChange Site Directed Mutagenesis Kit (Stratagene, La Jolla, CA) and sequenced to confirm the changes. The mutant and wild-type cultures were grown to saturation in 10-mL cultures, and the activity of the mutants, as well as the native β-glucuronidase and β-galactosidase, was verified in cell lysate (to represent pooling conditions) and in purified form following his-tag purification with Talon Metal Affinity Resin (BD Biosciences, San Jose, CA) using continuous monitoring of the change in absorbance at 405 nm. Forced dilutions to determine the limits of the assay were performed as for the wild type, but incubation times were increased to allow for the slower reaction. Again, the forced dilutions represent the worst-case scenario in detecting an improved mutant over background level of the wild type. Screening runs were conducted with 30 µL of the resorufin substrate solution (0.1 mM in 10 mM Tris-HCl, pH 7.5) and an incubation time of 9 h.
The assay of pools of T509A/S557P/N566S/K568Q as the supermutant and β-glucuronidase as the dud (AR = 15) was conducted at an SR of 1:10 4 and pooling levels of 1, 5, and 10 cells per well. Because of the cost of the resorufin substrate, sample sizes were limited to 10 plates per experiment. Growth conditions were as described for the β-galactosidase/β-glucuronidase experiments, and assay conditions were as described for the forced-dilution experiments.
Standard directed-evolution activity curve experiments
The T509A/S557P/N566S/K568Q mutant (AR = 15), the S557P/T509A mutant (AR = 2), wild-type β-glucuronidase (AR = 1), and cells harboring an empty plasmid (AR = 0) were mixed in appropriate ratios to reproduce a typical activity curve (Fig. 2) . Stage 1 experiments were conducted as described above for cell dilution procedures, using a pooling level of 5 cells per well and an unpooled control. After assay, the top 15 wells from the pooled experiment were streaked onto LB medium containing ampicillin and grown overnight. Six of the resulting colonies were chosen for each winning well from stage 1 and picked into 96-well plates for stage 2. As additional verification, 3 samples from each of the top 5 wells were made from the unpooled plate and picked into 96-well plates. The stage 2 colonies were grown overnight with agitation to stationary phase, 20 µL of each well was transferred to fresh medium, and cells were grown for an additional 17 h. Assays were conducted as described previously.
RESULTS
Simulations and direct calculations
Simulations were conducted using an AR of 15, 38,000, and 10 6 and an SR of 1:10 4 , 1:10 5 , and 1:10 6 , respectively. At the lowest activity ratio (15) , pooling conditions beyond 5 cells per well predicted finding supermutants in virtually all wells at all supermutant/dud ratios, a result of false positives. At activity ratios of 38,000 and above, the number of supermutants found increases linearly with the number of pooled cells per well, and more supermutants are found as the supermutant/dud ratio increases (example: Fig. 3 ). The predicted number of supermutants for an activity ratio of 38,000 and of 10 6 is nearly identical, indicating that once the activity ratio is far above the threshold of assay detection, the true number of supermutants is always detected. Theoretical calculations based on the Poisson distribution (see developments above) agree with the simulated results, for the most part, within a single standard deviation of the simulation (Fig. 4) .
Initial experimental validation
Initial experiments focused on 2 populations with a large difference in activity level. The activity ratio of cells expressing βgalactosidase to cells expressing native β-glucuronidase on oNPG in cell lysate was measured to be 38,000; thus, this number was used in simulations. Published estimates of the activity difference range up to 10 6 , but these are for pure enzymes and do not represent the screening conditions of a whole cell assay. In addition, as men- tioned above, simulations do not substantially differ for these activity ratios.
The cell dilution procedures were checked using flow cytometry. The discrepancy between the predicted concentration of cells per well and the counted one differed by only 5% to 10%. The agreement was far closer when flow cytometry was used as opposed to when spread plates were used to determine cell concentration.
The model was tested at supermutant/dud ratios of 1:10 4 to 1:10 6 . Most experiments were conducted at a supermutant/dud ratio of 1:10 5 because the largest difference in detection ability between pooled and unpooled experiments occurs here (central line of Fig. 4) . Additional experiments were conducted at the interesting endpoints of the 1:10 4 and 1:10 6 supermutant/dud ratio. In the former case, the model always predicts that a supermutant will be found, even if one does not do pooling. In the latter, the model predicts a very low probability of finding the supermutant, even at pooling levels of 100 cells per well. Figure 4 shows the comparison of the theoretical calculation, the simulation model, and the experimental results. For the supermutant/dud ratio of 1:10 5 , the calculations, simulations, and experimental results agree very closely, indicating that the model fits well. For the SR of 1:10 4 and 1:10 6 , the simulated and calculated results are slightly higher than the experimentally observed ones.
Forced-dilution experiments
Both to test the limits of pooling and to compare 2 assays of varying accuracy, artificial pools of cells expressing βgalactosidase and cells expressing β-glucuronidase were tested in the oNPG and resorufin assays. The main aim here was to estimate the highest level of pooling that could be employed using a very high level of background activity (i.e., the wild-type enzyme) as a worst-case scenario estimation. Figure 5 indicates that pools of 1:10 3 and higher do not allow for the detection of the supermutant from the background of the assay. This is true even when incubation times are increased (data not shown) and is probably a function of the relative rates of hydrolysis of the substrate by the supermutant and dud. Because our method involves visual inspection, it was also important that we be able to distinguish wells containing a supermutant by eye. This was much easier in the case of the resorufin assay, in which colors ranged from orange (unreacted) to magenta (fully reacted), versus in the oNPG assay, which calls for distinction between various shades of yellow (Fig. 6) . For the ortho-nitrophenylgalactopyranoside (oNPG) assay, 50 µL of 0.5 mM oNPG in 1× phosphate-buffered saline was added to each well, and well plates were incubated for 4 h at 30°C before being assayed spectrophotometrically at 405 nm. For the ResGal assay, 25 mL of 0.1 mM resorufin-β-Dgalactopyranoside in 10 mM Tris-HCl was added to each well, and plates were incubated at 30°C for 1.5 h. Fluorescence units were determined using a fluorimeter with excitation at 544 nm and emission monitored at 590 nm.
Experiments at lower activity level differences
Because differences in activity level of 38,000-fold are rare for mutants created by directed evolution, particularly in initial rounds, a mutant of β-glucuronidase (T509A/S557P/N566S/ K568Q) with 15-fold activity level difference in cell lysate was created. 19, 20 Pools of this mutant with cells expressing wild-type βglucuronidase were tested in forced-dilution experiments with both assays to determine the limits of pooling for spectrophotometric and visual detection. Again, the aim was to obtain a ballpark figure for the maximum level of pooling that could be tolerated in the system. For the oNPG assay, even pools of 1 mutant/2 wild type were barely distinguishable spectrophotometrically from the wildtype background (Fig. 7) . However, for the resorufin assay, ratios of up to 1 mutant/10 wild type were distinguishable both with the fluorimeter (Fig. 7) and visually (data not shown). Two additional mutants created in the process of making the quadruple mutant, S557P and T509A/S557P, both with approximately 2-fold increased specific activity over the wild-type Gus, were also assayed to determine whether they could be detected in pools. Neither of the mutants was distinguishable from wild-type Gus in either assay (Fig. 7) . Simulation results incorporating the coefficient of variation of both assays agree that pooling of these mutants with only wild-type β-glucuronidase is not worthwhile. However, later experiments suggest that when the activity curve is modified to contain a spectrum of mutants, pooling can be conducted with mutants of only 2-fold improved activity (see Standard Activity Distribution section).
To test the validity of the model at low activity ratios, experiments using the resorufin assay, a supermutant/dud ratio of 1:10 4 , and pools of 1, 5, and 10 cells per well were conducted with the quadruple mutant. Figure 8 compares the simulation and experimental results for these experiments. At an activity ratio of 15, there are a substantial number of false positives occurring in the simulation, particularly at and above 10 cells per well (data not shown). Once these are taken into account, the model predicts the number of supermutants detected fairly well. When an activity ratio of 35 (dashed line) is used to run the simulation, there are negligible numbers of false positives. Note that this simulation predicts the same number of supermutants as the previous simulation when the false positives are subtracted. Other supermutant/dud ratios were not tested because too few supermutants were expected in the small sample size necessary to use the resorufinated substrate. The ortho-nitrophenylgalactopyranoside (oNPG) assay was conducted as for the β-galactosidase and β-glucuronidase case (see Fig. 6 ), but incubation time was increased to 6 h (filled shapes). Bottom: The ResGal assay was conducted as for the β-galactosidase and β-glucuronidase case (see Fig. 6 ), but incubation time was increased to 9 h (open shapes, secondary axis).
Standard activity distribution
unpooled conditions after the 2nd stage. The simulation accurately predicts the number detected, regardless of the assay employed. This may seem in contrast with the forced-dilution experiments, but the presence of the inactive mutant means that the T509A/ S557P/N566S/K568Q (AR = 15) mutant can be detected with some probability (namely, when these end up in the same well). This more closely approximates a real directed-evolution experiment in which some of the variants created will have lower activity than the wild type, thereby lowering the average level of background activity.
DISCUSSION
Simulation results
The simulation results reflect the physical phenomena that the experimenter witnesses. For instance, when the activity level difference between the supermutant and dud is much larger than the assay accuracy, the simulation always detects the true number of supermutants present. Hence, the simulated numbers of supermutants for the activity level ratio of 38,000 and 10 6 are almost identical. In addition, simulations at a low activity ratio (e.g., 15 ) and a high pooling level (10 cells per well and higher) predict the occurrence of a supermutant in every well. The physical manifestation of this result would be the inability to distinguish between any of the wells because the pooling level is too high to allow for the detection of the supermutant within the error of the assay. Our simulation procedure allowed us to record which "supermutants" were false positives and false negatives. At low activity ratios, in experiments in which the wild-type enzyme serves as the background level of activity, a substantial number of false positives were detected, as evidenced by Figure 8 . In situations that more accurately reflect true directed-evolution experiments by including a percentage of inactive mutants, false positives are no longer a problem (Fig. 9 ). The number of false positives was negligible at higher activity ratios. The number of false negatives was insignificant in all cases.
Model validation
Overall, the experiments support that the model accurately predicts the number of supermutants that will be found for many cases. Among the variables accounted for in our Monte Carlo model, the supermutant/dud ratio has the largest impact on the number of supermutants detected. This is logical because the more supermutants produced in the diversity generation step of directed evolution, the higher the probability that one will be sampled for assay. In our experiments, when 1 supermutant was generated for every 10 4 duds, supermutants were detected even in the unpooled conditions. On the other hand, when 1 supermutant was generated for every 10 6 duds, even pooling 100 cells per well does not guarantee the detection of a supermutant in every experiment. The results indicate that the amount of diversity generated will greatly affect the success of the screening, and a minimum number of supermutants must be generated before screening is even worthwhile. Note that although supermutants are found in the 1:10 4 SR condition when pooling is not employed, the number of supermutants detected still increases when pooling is used. In an actual directed-evolution experiment in which there is not a single type of improved variant generated, it would still be beneficial to use pooling to bias the populations in future rounds toward higher activity mutants.
Utility of pooling in directed-evolution experiments
Pooling is most suited to cases in which an investigator is looking for a large increase in activity over the background level, such as the case in which one is attempting to evolve a new function in a protein. Here, pooling is aided by the fact that the background level of the activity is very low, making it easier to detect the presence of an improved mutant, even if the absolute level of improvement is very low. In this case, the number of mutants with the desired activity will be very few; therefore, pooling will be very useful in finding these few winners among the vast number with no activity. In addition, the wild-type parental gene is unlikely to have a high level of new desired activity in such an evolution experiment. FIG. 9 . Predicted and actual number (activity ratio [AR] = 15) of mutants detected when pooling with a more typical activity distribution. 16 Experiments were conducted using one 96-well plate for each stage.
Thus, the noise in the assay is minimized, increasing the number of cells that can be pooled before the background overwhelms the ability to detect. Preliminary evidence of this can be seen in the experiments approximating a standard activity distribution, in which we were able to find the 15-fold more active mutant with both assays as predicted by the model. Furthermore, we expect that the use of pooling will allow for a higher mutation load in error-prone PCR experiments, as more samples can be screened and high numbers of inactive mutants are actually beneficial, because they will not contribute to the background of the assay.
To use our model to guide directed-evolution experiments, investigators can input the assay accuracy, an estimate of the supermutant/dud ratio, and the desired activity increase that they wish to detect. The model will output the proper level of pooling to be used. In practice, the assay accuracy is most easily represented by the coefficient of variation seen when replicates are assayed. The supermutant/dud ratio can be estimated from initial library generation experiments or can be varied among likely values to determine the effect on the model. The desired activity level increase can also be varied, but our simulation results show that as long as the activity level increase is larger than the assay error, the supermutant will always be detected when present.
SUMMARY AND CONCLUSIONS
In summary, pooling is a method to increase the capacity of high-throughput screening assays. The Monte Carlo simulation model we have developed and validated can be used to predict the expected number of winners in directed-evolution experiments, given a putative distribution of activity over the population. This allows researchers to test several different scenarios before beginning experimentation. Even in cases in which the mutants created by the diversity generation step do not have a very large increase in activity level, pooling can be used if the background level of activity can be minimized. One way to accomplish this is by choosing the most sensitive assay possible. In our case, the resorufinated substrate allowed for a higher level of pooling in the forceddilution experiments. Another factor is the average level of background activity of the mutant population. When we compared slightly improved mutants to a background consisting of solely wild-type enzyme, it appeared that pooling would result in a large number of false positives. However, when the distribution was modified to contain a fraction of completely inactive mutants, which more accurately reflects the distribution of mutants obtained in directed-evolution experiments, our pooling model can accurately predict the number of mutants detected because the average level of background activity is lowered.
To use the model to aid in experimentation, end users can input their plate capacity, the number of wells in each plate, an estimated frequency that good mutants will be created, an estimation of the accuracy of the assay, and the activity level increase that they hope to find and use the model to determine the number of cells that should be pooled into each well for that experiment. The use of pooling will greatly increase the capacity of a laboratory to perform screening in directed-evolution experiments.
